GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Maat Pharma SA (XPAR:MAAT) » Definitions » Price-to-Funds-From-Operations

Maat Pharma (XPAR:MAAT) Price-to-Funds-From-Operations : (As of Apr. 12, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Maat Pharma Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Maat Pharma Business Description

Industry
Traded in Other Exchanges
Address
70 Avenue Tony Garnier, Lyon, FRA, 69007
Maat Pharma SA is a french clinical stage biotech and a pioneer in the development of microbiome based ecosystem therapies dedicated to improving survival outcomes for patients with cancer.